Is there a role for TNF-alpha antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi technique


Distler J. H. W., Jordan S., Airo P., Alegre-Sancho J. J., Allanore Y., Gurman A. B., ...Daha Fazla

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, cilt.29, sa.2, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 29 Sayı: 2
  • Basım Tarihi: 2011
  • Dergi Adı: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: scleroderma, TNF-alpha, fibrosis, NECROSIS-FACTOR-ALPHA, RANDOMIZED CONTROLLED-TRIALS, EULAR SCLERODERMA TRIAL, SYSTEMIC-SCLEROSIS, EOSINOPHILIC FASCIITIS, RHEUMATOID-ARTHRITIS, FIBROSING ALVEOLITIS, FATAL EXACERBATION, JOINT INVOLVEMENT, DOUBLE-BLIND
  • Marmara Üniversitesi Adresli: Hayır

Özet

Objective: To obtain experiences and expert opinion on treatment of SSc patients with TNF-alpha antagonists.